Galaxy Medicare Financial Statements
Galaxy Medicare financial statements. In FYNone, Galaxy Medicare (GML) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 7.3% and ROE of 7.5%. Full financial statements from FY2021 to FY2026 (6 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Galaxy Medicare share price screener.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
GML Revenue, Net Profit & EBITDA — Year-on-Year Growth
GML YoY (March 2026 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%. Read GML dividend growth for the complete payout history and dividend yield track record.
GML Income Statement — Revenue, EBITDA & Net Profit
Galaxy Medicare revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 7.3%. Analyse GML promoter holding to track promoter, FII and institutional holdings.
| Particulars | None | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 41 | 40 | 37 | 32 | 31 | 29 |
| Expenses | 0 | 36 | 35 | 31 | 29 | 27 | 27 |
| EBITDA | 0 | 6 | 6 | 6 | 3 | 3 | 3 |
| Operating Profit Margin % | 0.00% | 11.00% | 12.00% | 14.00% | 7.00% | 8.00% | 7.00% |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 0 | 5 | 5 | 5 | 2 | 0 | 1 |
| Tax | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
| Net Profit | 0 | 3 | 3 | 4 | 2 | 0 | 1 |
| Earnings Per Share (₹) | 0.00 | 2.50 | 2.84 | 3.13 | 5.17 | -0.70 | 2.56 |
GML Balance Sheet — Assets, Liabilities & Shareholders' Equity
GML total assets ₹49 Cr, total equity ₹40 Cr, total liabilities ₹ Cr (2026) — ROE 7.5%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Total Assets | 49 | 32 | 33 | 32 | 31 | 30 |
| Current Assets | 31 | 15 | 15 | 15 | 14 | 13 |
| Fixed Assets | 15 | 14 | 14 | 14 | 15 | 14 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 34 | 17 | 18 | 18 | 16 | 16 |
| LIABILITIES | ||||||
| Total Liabilities | ||||||
| Current Liabilities | 1 | 1 | 2 | 3 | 4 | 2 |
| Non-Current Liabilities | ||||||
| SHAREHOLDERS' EQUITY | ||||||
| Total Equity | 40 | 24 | 21 | 18 | 16 | 16 |
| Share Capital | 15 | 12 | 12 | 3 | 3 | 3 |
| Reserves & Surplus | 25 | 12 | 10 | 15 | 13 | 13 |
GML Cash Flow Statement — Operating, Investing & Financing
Galaxy Medicare operating cash flow ₹2 Cr, investing ₹-14 Cr, financing ₹12 Cr, net cash flow ₹0 Cr (2026).
| Particulars | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|---|
| Operating Activities | 2 | 5 | 3 | 4 | -1 | 6 |
| Investing Activities | -14 | 0 | -1 | -2 | -1 | -5 |
| Financing Activities | 12 | -5 | -2 | -2 | 1 | -1 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 |